Posted by Michael Wonder on 06 Apr 2026
MSAC publishes agenda for July 2026 MSAC meeting
7 April 2026 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC on 30-31 July 2026.
The agenda currently has 8 items. Applications of note include:
1782.1 – Genetic testing to detect oestrogen receptor 1 variants in patients with oestrogen receptor positive, HER2 negative, locally advanced or metastatic breast cancer to determine eligibility for treatment with PBS subsidised elacestrant
1818 – Expansion of specialist supervision criteria for MBS and PBS items for integrated, closed system, extracorporeal photopheresis and methoxsalen (Uvadex) for the treatment of cutaneous T-cell lymphoma and chronic graft versus host disease
